These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36434372)

  • 1. Management of Short Bowel Syndrome (SBS) and Intestinal Failure.
    Radetic M; Kamel A; Lahey M; Brown M; Sharma A
    Dig Dis Sci; 2023 Jan; 68(1):29-37. PubMed ID: 36434372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
    Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
    Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
    Germán-Díaz M; Alcolea A; Cabello V; Blasco-Alonso J; Rodríguez A; Galera R; García-Romero R; Romero C; González-Sacristán R; Redecillas-Ferreiro S; Moreno-Villares JM; Ramos-Boluda E
    Eur J Pediatr; 2024 Aug; 183(8):3173-3182. PubMed ID: 38664251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
    Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.
    Seidner DL; Schwartz LK; Winkler MF; Jeejeebhoy K; Boullata JI; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2013 Mar; 37(2):201-11. PubMed ID: 23343999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study.
    Mizushima T; Udagawa E; Hasegawa M; Tazuke Y; Okuyama H; Fernandez J; Nakamura S
    Surg Today; 2022 Sep; 52(9):1350-1357. PubMed ID: 35195767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding short bowel syndrome: Current status and future perspectives.
    Massironi S; Cavalcoli F; Rausa E; Invernizzi P; Braga M; Vecchi M
    Dig Liver Dis; 2020 Mar; 52(3):253-261. PubMed ID: 31892505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
    de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
    J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K; Schwartz L; Batisti J; Iyer KR
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
    Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.